Laboratory‐AcquiredClostridium difficilePolymerase Chain Reaction Ribotype 027: A New Risk for Laboratory Workers?
Author(s) -
Emilio Bouza,
Adoración Martín,
R.J. van den Berg,
Ed J. Kuijper
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/593109
Subject(s) - clostridium difficile , medicine , polymerase chain reaction , clostridiaceae , microbiology and biotechnology , clostridium , clostridiales , bacteria , gene , antibiotics , biology , genetics , toxin
Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganism and promotes complement deposition. Effect of capsulation of opportunistic patho-genic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.tality and time for detection of blood growth in patients with Staphylococcus aureus bacter-emia: implication of the mannose-binding lec-tin pathway. In: Program and abstracts of the 17th European Society of Clinical Microbiology and Infectious Diseases (Munich). 2007: 1753. To the Editor—Mannose-binding lectin (MBL) deficiency has been associated with a predisposition to numerous infectious diseases, and our recent data indicate that patients with pneumococcal infection who have MBL levels !0.5 mg/mL are more likely to die [1]. The data included in our recent meta-analysis excluded the initial study that showed a strong association between MBL2 variant allele homozygosity and invasive pneumococcal infection [2], because these patients' MBL blood levels were not measured. If these patients could have been included, the association we ascertained between MBL deficiency and death in pneumococcal infection would very likely have been even stronger than our finding of an OR of 5.62 (95% CI, 1.27–24.92). In their letter, Smithson et al. [3] indicate that conclusions regarding the significance of MBL deficiency need to be viewed in the context of in vitro data that describe the binding of this protein to bacterial cells and the consequent deposition of complement. The earliest data relating to Streptococcus pneumoniae demonstrated binding of the bacteria to MBL [4], but more-recent data indicate that encapsu-lation of pneumococci abrogates binding [5]. One crucial aspect of the contribution of MBL to the killing of pneumococci that has not been studied to date is the contribution of neutrophils. Until these data are available, it is premature to ignore the strong association between MBL deficiency and poor outcomes of pneumo-coccal infection. It is important to examine the possible association between Staphylococcus aureus sepsis and MBL deficiency, because of the in vitro observations of MBL binding to S. aureus and the resulting increased phag-ocytosis [6]. The only published data on S. aureus sepsis come from our 2 studies [1, 7] and are summarized in the recent meta-analysis. On the basis of 49 patients with staphylococcal sepsis, no clear association with MBL deficiency was demonstrated. If we assume that the magnitude of effect of MBL deficiency is the same in staphylococcal and pneumococcal sepsis, a minimum sample size of 60 would be required …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom